Canada...

20 February 2022

In a new study by researchers at McMaster University of Canada, they found that regular caffeine consumption was associated with low levels of a protein called PCSK9 in the bloodstream.

The study identified that certain proteins interact with caffeine in coffee, which helps the liver remove bad cholesterol from the bloodstream, thereby protecting against cardiovascular disease.

Low levels of this protein enhance the ability of the liver to break down LDL cholesterol, the "harmful" type that can block the arteries and lead to cardiovascular disease.

In the study published in the journal Netcher Communicators, researchers also found that caffeine also inhibits the activation of another protein called SRIBP2, which also reduces the levels of PCSK9 in the blood.

Senior author of the study, Richard Austin, noted that: "The results of the study revealed the basic mechanism by which caffeine and its derivatives can mitigate the levels of PCSK9 in the blood, thereby reducing the risk of cardiovascular disease," New Atlas reported.

The researchers warned that mixing coffee with sugar or cream would eliminate any benefits for caffeine, also giving rise to the risk of eating energy drinks that also contain this compound.